{"answers":{"affected":"It affects 1 product.","exploited":"There is no known exploitation of CVE-2017-18228 in the wild and no public exploit code.","fix":"No fix has been published for CVE-2017-18228 yet. Limit exposure of the affected software until one is available.","what":"CVE-2017-18228 is a medium-severity cross-site scripting vulnerability in n/a, published on 12 Mar 2018. Any signed-in user can exploit it over the network, and only if a user opens a file or follows a link."},"fix_prompt":"Check this codebase for CVE-2017-18228 and fix it if it is affected.\n\nWhat it is: CVE-2017-18228 is a medium-severity cross-site scripting vulnerability in n/a, published on 12 Mar 2018. Any signed-in user can exploit it over the network, and only if a user opens a file or follows a link.\nExploitation: There is no known exploitation of CVE-2017-18228 in the wild and no public exploit code.\n\nAffected product: n/a. No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2017-18228/ (Markdown: https://insights.sbomify.com/CVE-2017-18228/index.md)","id":"CVE-2017-18228","markdown":"https://insights.sbomify.com/CVE-2017-18228/index.md","name":"CVE-2017-18228","record":{"aliases":["GHSA-xpwq-6mfc-rr7g"],"analysis":{"component_type":"web_application","fix_type":"patch","impacts":["code_execution","account_takeover"],"network_reachable":"yes","non_default_config":false,"product_category":"BMC Remedy AR System","requires_auth":"low_privilege","summary":"Cross-site scripting in BMC Remedy AR System allows attackers to inject scripts via the ATTKey parameter, potentially leading to session hijacking or code execution.","user_interaction":"required","vuln_class":"xss"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"mitre","cpe":[{"product":"remedy_action_request_system","vendor":"bmc"}],"cvss":{"score":5.4,"severity":"medium","source":"nvd","vector":"CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N","version":"3.0"},"cwes":[{"id":"CWE-79","name":"Improper Neutralization of Input During Web Page Generation"}],"description":"Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet request.","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"none_known"},"has_fix":null,"headline":"Cross-site scripting in n/a","id":"CVE-2017-18228","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"xss","year":"2017"},"n_packages":0,"n_references":1,"next":{"headline":"Denial of service in n/a","id":"CVE-2017-18229"},"packages":[],"prev":{"headline":"Security feature bypass in n/a","id":"CVE-2017-18227"},"products":["n/a"],"published":"2018-03-12","related":[{"cvss_score":8.8,"headline":"Missing authorization in n/a","id":"CVE-2018-18862","kev_date_added":null,"published":"2019-03-17"},{"cvss_score":8.1,"headline":"Auth bypass in n/a","id":"CVE-2017-18223","kev_date_added":null,"published":"2018-03-10"},{"cvss_score":7.5,"headline":"Auth bypass in n/a","id":"CVE-2016-2349","kev_date_added":null,"published":"2016-12-21"},{"cvss_score":6.1,"headline":"Cross-site scripting in n/a","id":"CVE-2015-9257","kev_date_added":null,"published":"2018-03-24"},{"cvss_score":5,"headline":"Information disclosure in n/a","id":"CVE-2007-0310","kev_date_added":null,"published":"2007-01-18"}],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"US public information, NVD API terms","name":"NVD"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":null,"exploitation":null,"technical_impact":null},"state":"PUBLISHED","updated":"2024-09-16","vendors":["n/a"]},"summary":"Cross-site scripting in BMC Remedy AR System allows attackers to inject scripts via the ATTKey parameter, potentially leading to session hijacking or code execution.","url":"https://insights.sbomify.com/CVE-2017-18228/"}